Markets › United States › NAS › ALGS

Aligos Therapeutics Inc

NAS:ALGSHealthcarenasdaq_composite

$4.84+0.31%LiveIn session · ≈ AED 17.76 · Market cap $30.19M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	100.0%	100.0%	100.0%	100.0%	57.5%	—	—
Operating margin	—	−2,943.8%	−701.7%	−567.5%	−2,259.9%	−4,024.9%	−4,024.9%	+0.0 pts
Net margin	—	−2,944.1%	−690.6%	−564.6%	−3,326.0%	−1,106.7%	−1,106.7%	+0.0 pts
EBITDA margin	—	−2,854.1%	−663.4%	−539.7%	−3,251.2%	−1,049.8%	—	—
Return on equity	−49.3%	−69.5%	−92.4%	−95.2%	452.9%	−45.2%	−45.2%	+0.0 pts
Return on assets	−40.9%	−54.5%	−65.5%	−57.9%	−187.2%	−27.3%	−27.3%	+0.0 pts
Return on capital employed	−41.6%	−65.3%	−85.9%	−69.1%	−184.4%	−130.7%	—	—
Debt / equity	0.1×	0.1×	0.1×	0.1×	−0.3×	0.1×	0.1×	+0.0%
Debt / assets	4.9%	6.1%	8.6%	7.4%	11.9%	5.9%	—	—
Interest coverage	−9.3×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	8.3×	5.2×	4.0×	5.9×	2.9×	3.9×	3.9×	+0.0%
Quick ratio	8.3×	5.2×	4.0×	5.9×	2.9×	3.9×	—	—
Cash ratio	7.3×	4.8×	2.5×	5.7×	1.7×	0.9×	0.9×	+0.0%
Asset turnover	0.0×	0.0×	0.1×	0.1×	0.1×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—